Screening test for coeliac disease Sir, In the paper by Challacombe et al. (1975) concerning urinary 5-hydroxyindoleacetic acid (5-HIAA) in coeliac disease, it is stated that the urinary 5-HIAA:creatinine ratio may be useful as 'an aid in the diagnosis of coeliac disease'. The critical question is, Does the finding of a normal urinary 5-HIAA: creatinine ratio justify the omission of jejunal biopsy when the diagnosis of coeliac disease is being considered ? Since their own data indicate that more than half(10/18) ofpatients with coeliac disease have values for this ratio within the normal range, the answer appears to be no. Though the reported findings are interesting in themselves, the authors' claim that the test has diagnostic value is difficult to justify. As with other 'screening' tests for coeliac disease which have been proposed in the past, the discriminating power of this ratio is unacceptably low. The only safe rule continues to be: when in doubt-biopsy.
GEORGE The letter by Dr. Haycock poses two interesting questions which have both been answered in the text of our paper (Challacombe et al., 1975) . The finding of a normal urinary 5-HIAA creatinine ratio does not justify the omission of jejunal biopsy when the diagnosis of coeliac disease is under consideration. However, it remains a useful aid in deciding whether small intestinal biopsy should be performed. Overlap of the data mentioned by Dr. Haycock and shown in Fig. 2 was almost entirely due to an age-related change in the ratio. Fig. 1 shows that 'when coeliac disease results were compared with results from control children of similar age only one was exceeded by a control value'.
Study of 5-HIAA excretion in coeliac disease is continuing and results still indicate that the 5-HIAA creatinine ratio is a useful aid in the diagnosis of coeliac The patient receives quinalbarbitone and metoclopramide orally in a dose appropriate for his age, as recommended by Townley and Barnes (1973) . One hour later, when the child is well sedated, the capsule is swallowed and the child placed in the right lateral position for a further hour. During this period gas is intermittently aspirated from the stomach using a 50 ml syringe. The position of the capsule is then located by brief screening. If the capsule has not passed through the pylorus by this time any significant quantity of air remaining in the stomach is removed by further aspiration and then simple manipulation of the Ryle's tube is used to push the capsule through the pylorus, after which it usually passes rapidly into the jejunum. If there is any difficulty -in-getting the capsule to pass through the pylorus, the child is turned and the effect of gravity used and 5 ml metoclopramide injected gently down the tube of the biopsy capsule to stimulate peristalsis. This invariably leads to successful passage of the capsule into the jejunum.
Using Dobbs and Cremer (1975) on the origins of phototherapy, but the latter does himself less than justice if he thinks that the advantages of phototherapy he described so well in 1958 were not appreciated in this country. Phototherapy was started in the Derby Special Care Baby Unit soon after the publication of his paper, although a carefully controlled study of its value in preterm babies was not published until much later. The results (Elliott, Moncrieff, and George, 1974) fully confirmed Dr. Cremer's original work, as does a later study on very low birthweight babies (Moncrieff and Dunn, 1976 
